Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Ogg

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
JCI Insight|June 6, 2020
Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild diseaseYan Zhao, Ling Qin, Ping Zhang, et al.
The Journal of Experimental Medicine|May 7, 2021
CD1a selectively captures endogenous cellular lipids that broadly block T cell responseRachel N Cotton, Marcin Wegrecki, Tan-Yun Cheng, et al.
Science Translational Medicine|February 12, 2016
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipaseRachael Jarrett, Mariolina Salio, Antonia Lloyd-Lavery, et al.
Iscience|November 3, 2021
The impact of viral mutations on recognition by SARS-CoV-2 specific T cellsThushan I de Silva, Guihai Liu, Benjamin B Lindsey, et al.
Allergy|July 22, 2020
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelinesIoana Agache, Yang Song, Margarita Posso, et al.
Mucosal Immunology|December 7, 2018
Correction: Synergistic activation of pro-inflammatory type-2 CD8 <sup>+</sup> T lymphocytes by lipid mediators in severe eosinophilic asthmaBart Hilvering, Timothy S C Hinks, Linda Stöger, et al.
Mucosal Immunology|June 17, 2018
Synergistic activation of pro-inflammatory type-2 CD8<sup>+</sup> T lymphocytes by lipid mediators in severe eosinophilic asthmaBart Hilvering, Timothy S C Hinks, Linda Stöger, et al.
The British Journal of Dermatology|January 29, 2025
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohortElizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, et al.
Nature Communications|October 1, 2025
Long-persisting SARS-CoV-2 spike-specific CD4<sup>+</sup> T cells associated with mild disease and increased cytotoxicity post COVID-19Guihai Liu, Elie Antoun, Anastasia Fries, et al.
Allergy|August 9, 2020
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals GuidelinesIoana Agache, Claudio Rocha, Ana Pereira, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
JCI Insight|June 6, 2020
Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild diseaseYan Zhao, Ling Qin, Ping Zhang, et al.
The Journal of Experimental Medicine|May 7, 2021
CD1a selectively captures endogenous cellular lipids that broadly block T cell responseRachel N Cotton, Marcin Wegrecki, Tan-Yun Cheng, et al.
Science Translational Medicine|February 12, 2016
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipaseRachael Jarrett, Mariolina Salio, Antonia Lloyd-Lavery, et al.
Iscience|November 3, 2021
The impact of viral mutations on recognition by SARS-CoV-2 specific T cellsThushan I de Silva, Guihai Liu, Benjamin B Lindsey, et al.
Allergy|July 22, 2020
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelinesIoana Agache, Yang Song, Margarita Posso, et al.
Mucosal Immunology|December 7, 2018
Correction: Synergistic activation of pro-inflammatory type-2 CD8 <sup>+</sup> T lymphocytes by lipid mediators in severe eosinophilic asthmaBart Hilvering, Timothy S C Hinks, Linda Stöger, et al.
Mucosal Immunology|June 17, 2018
Synergistic activation of pro-inflammatory type-2 CD8<sup>+</sup> T lymphocytes by lipid mediators in severe eosinophilic asthmaBart Hilvering, Timothy S C Hinks, Linda Stöger, et al.
The British Journal of Dermatology|January 29, 2025
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohortElizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, et al.
Nature Communications|October 1, 2025
Long-persisting SARS-CoV-2 spike-specific CD4<sup>+</sup> T cells associated with mild disease and increased cytotoxicity post COVID-19Guihai Liu, Elie Antoun, Anastasia Fries, et al.
Allergy|August 9, 2020
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals GuidelinesIoana Agache, Claudio Rocha, Ana Pereira, et al.
Pageof 9